Understanding APC - malecare.org

Changes of PSA Doubling Time is Associated with Disease Progression in Men with Biochemically Relapsed Prostate Cancer Treated with Intermittent Androgen Deprivation

Researchers at the The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland studied the relationship between the change of PSA doubling time (PSADT) and disease progression during intermittent androgen deprivation (IAD) therapy for prostate cancer. They retrospectively analyzed the data from 96 men diagnosed with biochemically relapsed prostate cancer (BRPC) who [...]

By Malecare|2017-10-19T10:53:12-04:00April 17th, 2011|Advanced Prostate Cancer, Drugs & Treatments, Hormone Therapy, Uncategorized, Understanding APC|0 Comments

Pomegranate and Its Role In PSA Velocity

In 2005 there was a small clinical trial performed at UCLA evaluating pomegranate juice and its ability to control PSA for men with prostate cancer. The trial gave 8 oz. of POM Wonderful pomegranate juice each day in men with a rising PSA post treatment (recurrent advanced prostate cancer). This trial, which was funded by [...]

By Malecare|2020-02-04T10:12:43-05:00April 11th, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Diet and Supplements, General Information, How We Live, Me, Research, Uncategorized, Understanding APC|1 Comment

Dendreon Gets FDA Approval for Extra Work Stations at their New Jersey Factory

On March 10th (my birthday) Dendreon announced that it has obtained clearance of its new work stations from the FDA. The result of this clearance is the quadrupling the output from the New Jersey factory where it makes sipuleucel-T (Provenge). When Dendreon obtained FDA clearance in April of 2010, it had extremely limited manufacturing capabilities [...]

By Malecare|2011-04-06T12:16:49-04:00April 6th, 2011|Advanced Prostate Cancer, Drugs & Treatments, General Information, Uncategorized, Understanding APC, vaccines|0 Comments

We Still need Your Support To Insure The Survival of the Prostate Cancer Research Program (PCRP)

I have been writing about the dire need for us to reach out to our congressional delegates and demand they support funding for the Prostate Cancer Research Program (PCRP). If you have not yet contacted your congressional members, please do it. Don’t forget you also need to let your entire email list and address book [...]

By Malecare|2021-04-29T10:07:34-04:00March 29th, 2011|Advanced Prostate Cancer, Advocacy, DOD, Uncategorized, Understanding APC|0 Comments

Study Shows that Six Months of Neoadjuvant ADT Significantly Reduces Mortality in Locally Advanced Prostate Cancer

Researchers from the Trans-Tasman Radiation Oncology Group 96.01 trial study (TROG 96.01) concluded that six months of treatment with neoadjuvant androgen deprivation combined with radiation reduced the risk for disease-specific death by 49% in men with locally advanced prostate cancer. […]

By Malecare|2011-03-28T13:49:05-04:00March 28th, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, General Information, Hormone Therapy, Radiotherapy, Research, Uncategorized, Understanding APC, United Kingdom - England, Northern Ireland, Scotland & Wales|0 Comments